(Q56898082)

English

Interferon alpha therapy in HBeAg-negative chronic hepatitis B: new data in support of long-term efficacy

No description defined

In more languages

edit

Statements

0 references

0 references

1 reference

Europe PubMed Central

title

Interferon alpha therapy in HBeAg-negative chronic hepatitis B: new data in support of long-term efficacy (English)

0 references

1 reference

1 reference

Stephanos J Hadziyannis

series ordinal

1

0 references

language of work or name

English

0 references

publication date

February 2002

0 references

published in

Journal of Hepatology

0 references

volume

36

0 references

issue

2

0 references

page(s)

280-2

0 references

cites work

Management of hepatitis B: 2000--summary of a workshop

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis B e antigen-negative chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigen

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0168-8278%2801%2900314-2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0168-8278(01)00314-2

0 references

PubMed publication ID

11830342

0 references

(Q56898082)

Interferon alpha therapy in HBeAg-negative chronic hepatitis B: new data in support of long-term efficacy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)